Comparison of SSRIs and SNRIs in major depressive disorder: a meta‐analysis of head‐to‐head randomized clinical trials

@article{Machado2010ComparisonOS,
  title={Comparison of SSRIs and SNRIs in major depressive disorder: a meta‐analysis of head‐to‐head randomized clinical trials},
  author={M{\'a}rcio Machado and Thomas R Einarson},
  journal={Journal of Clinical Pharmacy and Therapeutics},
  year={2010},
  volume={35}
}
  • M. Machado, T. Einarson
  • Published 1 April 2010
  • Psychology, Biology
  • Journal of Clinical Pharmacy and Therapeutics
Context:  Controversy exists whether serotonin–norepinephrine reuptake inhibitors (SNRIs) have improved efficacy compared with selective serotonin reuptake inhibitors (SSRIs). 
View on Wiley
ncbi.nlm.nih.gov
34 Citations
Highly Influential Citations
1
Background Citations
9
Methods Citations
1
Results Citations
1

34 Citations

Citation Type

Citation Type

Duloxetine: a review of its use in the management of major depressive disorder in older adults.
TLDR
Current evidence suggests that treatment with duloxetine may be beneficial in older adults with major depressive disorder, and its pharmacological properties are summarized.
Major Depressive Disorder and Kappa Opioid Receptor Antagonists
TLDR
It will be not surprising to predict the potential success of ALKS 5461 (a combination of buprenorphine and ALKS-33) in the near future and CERC-501 will be expected to be available as monotherapy or adjuvant therapy with other first-line antidepressants in the treatment of TRD, if ongoing clinical trials continue to provide positive benefit-risk profiles.
Efficacy and Safety of Selective Serotonin Reuptake Inhibitors , Serotonin-Norepinephrine Reuptake Inhibitors , and Placebo for Common Psychiatric Disorders Among Children and Adolescents
TLDR
Analysis showed that SSRIs and SNRIs were significantly more beneficial compared with placebo, yielding a small effect size for ADs, while patients receiving an antidepressant reported significantly more treatment-emergent adverse events.
Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder
TLDR
MDD treatment with vilazodone was associated with significantly lower rates of inpatient and emergency services, and with significant lower all-cause medical service costs and numerically (non-significantly) lower total costs to payers than with the other SSRIs included in this study.
Comparação entre SNRI e SSRI na indução da remissão da perturbação depressiva major: uma revisão baseada na evidência
TLDR
Evaluated SNRI and SSRI are both evidence-based choices for induction of remission in depression and the choice of a SNRI over a SSRI to achieve remission of depression is not supported by the current evidence.
Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis
TLDR
Compared with placebo, SSRIs and SNRIs are more beneficial than placebo in children and adolescents; however, the benefit is small and disorder specific, yielding a larger drug-placebo difference for AD than for other conditions.
Drug Class Review: Second-Generation Antidepressants
The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage…
Drug Class Review: Second-Generation Antidepressants: Final Update 5 Report
The purpose of Drug Effectiveness Review Project reports is to make available information regarding the comparative clinical effectiveness and harms of different drugs. Reports are not usage…
Efficacy of acupuncture treatment of sexual dysfunction secondary to antidepressants.
TLDR
A potential role for acupuncture is suggested in the treatment of the sexual side-effects of SSRIs and SNRIs as well for a potential benefit of integrating medical and complementary and alternative practitioners.
Gambling on treatment is not an option
  • Psychology, Medicine
  • 2016
TLDR
The annual Latest Advances in Psychiatry Symposium provided an update on topics from eating disorders and problem gambling to management guidelines for schizophrenia and depression, and attention deficit hyperactivity disorder (ADHD) in adults.
...
1
2
3
4
...

References

SHOWING 1-10 OF 73 REFERENCES
Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression
TLDR
SSRIs seem to be as well tolerated as moclobemide, mirtazapine, venlafaxine, reboxetine and nefazodone and show comparable efficacy.
A double‐blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia
TLDR
The antidepressant efficacy and short-term safety of venlafaxine and fluoxetine were compared in 68 patients hospitalized with major depression and melancholia and overall tolerance was similar for the two treatments.
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
TLDR
SERTraline and venlafaxine XR demonstrated comparable effects on QOL and efficacy in treatment of major depression, although sertraline may be associated with a lower symptom burden during treatment discontinuation and a reduced risk of blood pressure increase.
Efficacy of Duloxetine and Selective Serotonin Reuptake Inhibitors: Comparisons as Assessed by Remission Rates in Patients With Major Depressive Disorder
TLDR
Whereas duloxetine and the 2 SSRIs were comparably efficacious overall, therapy with the serotonin and norepinephrine reuptake inhibitor resulted in a significantly higher remission rate among patients with moderate-to-severe depression.
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
TLDR
Although response and remission rates did not differ statistically, the rates were analogous to those reported in previous meta-analyses, however, at clinically relevant higher doses, the remission rates were very similar.
[Comparative naturalistic study of the efficacy and tolerability of new antidepressants].
TLDR
Comparing the efficacy and tolerability of currently available Selective Serotonin Re-uptake Inhibitors and venlafaxine in out-patients from a primary psychiatric-care center found fluoxetine was associated with the lowest incidence of adverse effects in a logistical regression model.
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression
Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
TLDR
It is suggested that men and women have comparable responses to SSRIs and venlafaxine across various age groups and patients exhibited a more rapid onset and a greater likelihood of remission with venl Lafaxine therapy than with SSRI therapy regardless of age or gender.
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.
TLDR
Venlafaxine has greater efficacy than SSRIs although there is uncertainty in comparison with other antidepressants, and further studies are required to determine the clinical importance of this finding.
Dual Monoamine Modulation for Improved Treatment of Major Depressive Disorder
TLDR
Clinical evidence suggests that a number of novel antidepressant drugs, including mirtazapine, milnacipran, venlafaxine, and duloxetine have been developed and may offer improved efficacy and/or faster onset of action compared with SSRIs and an improved side effect profile compared with TCAs.
...
1
2
3
4
5
...